ASH Letter re FDA Draft on Pediatric Drug Development

American Society of Hematology. (1).
ASH Letter re FDA Draft on Pediatric Drug Development.
Retrieved from https://xp103-eus-mc-prd-sitecore-cd-stage.azurewebsites.net/advocacy/testimony-and-correspondence/ash-letter-re-fda-draft-on-pediatric-drug-development.

American Society of Hematology.
"ASH Letter re FDA Draft on Pediatric Drug Development." Hematology.org.
https://xp103-eus-mc-prd-sitecore-cd-stage.azurewebsites.net/advocacy/testimony-and-correspondence/ash-letter-re-fda-draft-on-pediatric-drug-development
(label-accessed July 19, 2025).

"American Society of Hematology."
ASH Letter re FDA Draft on Pediatric Drug Development, 19 Jul. 2025 ,
https://xp103-eus-mc-prd-sitecore-cd-stage.azurewebsites.net/advocacy/testimony-and-correspondence/ash-letter-re-fda-draft-on-pediatric-drug-development.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero